KRT88P and tuberculosis: Consequently, screening for HBV and HCV markers (including HBsAg, anti-HBs, anti-HBc and anti-HCV) and the TB GOLD QuantiFERON test are mandatory in all patients who need anti-TNF therapy [32,33,34,35,36,37].